10 Best Consumer Stocks To Invest In 2015

10 Best Consumer Stocks To Invest In 2015: Walgreen Co (WAG)

Walgreen Co. (Walgreens), incorporated on February 15, 1909, together with its subsidiaries, operates the drugstore chain in the United States. The Company provides its customers with access to consumer goods and services, pharmacy, and health and wellness services in communities across America. The Company offers its products and services through drugstores, as well as through mails, by telephone and online. The Company sells prescription and non-prescription drugs, as well as general merchandises, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. On August 2, 2012, it acquired 45% interest in Alliance Boots GmbH (Alliance Boots). In September 2012, the Company completed the purchase of a regional drugstore chain in the mid-South region of the United States that included 144 stores operated under the USA Drug, Super D Drug, Mays, Med-X and Drug Warehouse names. In September 2012, WP Carey & Co LLC acquired fiv e retail stores leased to Walgreen Co. In December 2012, the Company completed a transaction giving company a ownership stake in Cystic Fibrosis Foundation Pharmacy LLC.

The Company's pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service, convenient care clinics and worksite health and wellness centers. These services help improve health outcomes and manage costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The Company's Take Care Health Systems subsidiary is a manager of worksite health and wellness centers and in-store convenient care clinics, with more than 700 locations throughout the United States.

As of August 31, 2012, Walgreens operated 8,385 locations in 50 states, the District of Columbia, Guam and Puerto Rico. In 2012, the Company opened or acquired 266 locations for a net increase of 175 lo! cations af ter relocations and closings. As of August 31, 2012, the Com! pany had 7,930 of Drugstores, 366 of Worksite Health and Wellness Centers, 76 of Infusion and Respiratory Services Facilities, 11 of Specialty Pharmacies and two of Mail Service Facilities. The Company's drugstores are engaged in the retail sale of prescription and non-prescription drugs and general merchandise. General merchandise includes, among other things, household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy.

The Company offers specialty pharmacy services that provide customers nationwide access to a variety of medications, services and programs for managing complex and chronic health conditions. In addition, the Company offers its customers infusion therapy services, including the administration of intravenous (IV) medications for cancer treatments, chronic pain, heart failure, and other infections and disorders which must be treated by IV. Walgreens provides these infusion services at home, at the workplace, in a physician's office or at a Walgreens alternate treatment site. The Company also provides clinical services, such as laboratory monitoring, medication profile review, nutritional assessments and patient and caregiver education.

Customers can also access the Company's e-commerce solutions, which extend the convenience to purchase most products available within its drugstores, as well as additional products sold exclusively online through its walgreens.com and drugstore.com Websites, including beauty.com and visiondirect.com. The Company's Websites allow consumers to purchase general merchandise including beauty, personal care, home medical equipment, contact lenses, vitamins and supplements and other health and wellness solutions. The Company's mobile applications also allow customers to refill prescriptions through their mobile device, download weekly promotions and find the nearest Walgreens drugstore. The Company also offers services throu! gh Take C! are Heal th Systems, which manages its Take Care Clinics at select Wa! lgreens d! rugstores throughout the country.

Alliance Boots is a pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution business. As of March 31, 2012, its fiscal year end, Alliance Boots had, together with its associates and joint ventures, pharmacy-led health and beauty retail businesses in 11 countries and operated more than 3,330 health and beauty retail stores, of which over 3,200 had a pharmacy. In addition, Alliance Boots had approximately 625 optical practices, approximately 185 of which operated on a franchise basis. Its pharmaceutical wholesale and distribution businesses, including its associates and joint ventures, supplied medicines, other healthcare products and related services to more than 170,000 pharmacies, doctors, health centers and hospitals from over 370 distribution centers in 21 countries.

Alliance Bootss stores located in the United Kingdom, Norway, the Republic of Ireland, the Netherlands, Thaila nd and Lithuania and through its associates and joint ventures in Switzerland, China, Italy, Russia and Croatia. In addition, as of March 31, 2012, there were 58 Boots stores operated in the Middle East on a franchised basis. In its Health & Beauty Division, Alliance Boots has product brands such as No7, Soltan and Botanics, together with other brands, such as Boots Pharmaceuticals and Boots Laboratories. Through its Pharmaceutical Wholesale Division and several of its associates, Alliance Boots sells Almus, its line of generic medicines, in five countries and Alvita, its line of patient care products, in six countries.

Advisors' Opinion:

• [By Keith Speights]

  Ouch. If you own Walgreen (NYSE: WAG  ) stock, you're likely feeling some pain after Tuesday's drop of nearly 6%. Shares fell the most in months on news that the big pharmacy chain missed the consensus earnings estimates for its fiscal 2013 third quarter.! Does the! pullback present a good opportunity to buy the stock? Let's take a look.

• [By Dividends4Life]

  Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CVX is trading at a discount to only 3.) above. The stock is trading at a 44.9% premium to its calculated fair value of $82.00. CVX did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CVX earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CVX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1912 and has increased its dividend payments for 27 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $256 is below the $800 target I look for in a stock that has increased dividends as long as CVX has. The stock's current yield of 3.37% exceeds the 3.31% estimated 20-year average MMA rate. Memberships and Peers: CVX is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers Index and a Dividend Champion. Th! e company! 's peer group includes: BP plc (BP) with a 4.7% yield, Exxon Mobil

• [By Caroline Bennett]

  Pharmacy chain Walgreen (NYSE: WAG  ) and the U.S. Drug Enforcement Administration and Department of Justice have reached a settlement agreement over civil charges that the company had practiced improper distribution of prescription painkillers, the company announced yesterday.

• [By John Divine]

  The biggest laggard of the day, stock in the drugstore Walgreen (NYSE: WAG  ) , cratered 5.9%, even after profits rose 16% from the comparable quarter last year. Today's slide is just another example of how businesses that are growing at healthy clips can still see their stock prices crumble if growth isn't strong enough to meet expectations. Walgreen certainly shows all the signs of a mature business at this stage -- revenue rose just 3%, coming in at $18.31 billion in the quarter, $90 million below what analysts were looking for.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/10-best-consumer-stocks-to-invest-in-2015.html